Nano-Polymer Stents May Reach U.S. Market By 2007 At Half The Cost Of DES
This article was originally published in The Gray Sheet
Executive SummaryPolyphosphaze non-carbon-based nano-polymers potentially will offer the same anti-restenosis benefits as drug-eluting stents, but cost only slightly more than bare-metal versions, according to Götz Richter, MD/PhD, University of Heidelberg, Germany
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.